Intelligent Bio Solutions Stock Investor Sentiment
| INBS Stock | USD 1.52 0.03 1.94% |
Slightly above 54% of Intelligent Bio's investor base is interested to short. The analysis of overall sentiment of trading Intelligent Bio Solutions stock suggests that many investors are impartial at this time. Intelligent Bio's investing sentiment can be driven by a variety of factors including economic data, Intelligent Bio's earnings reports, geopolitical events, and overall market trends.
Comfort Level 46
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Intelligent Bio's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Intelligent Bio Solutions.
News SentimentBullish | Hype SentimentBearish | Insider SentimentWaiting |
Intelligent Historical Sentiment
Although Intelligent Bio's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Intelligent, such as negative comments on social media and news outlets, may cause fear in the market and push Intelligent Bio's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Intelligent.
Intelligent | Build AI portfolio with Intelligent Stock |
Intelligent Bio Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Intelligent Bio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Intelligent Bio Solutions Historical Investor Sentiment
Investor biases related to Intelligent Bio's public news can be used to forecast risks associated with an investment in Intelligent. The trend in average sentiment can be used to explain how an investor holding Intelligent can time the market purely based on public headlines and social activities around Intelligent Bio Solutions. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Intelligent Bio's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Intelligent Bio and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Intelligent Bio news discussions. The higher the estimate score, the more favorable the investor's outlook on Intelligent Bio.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Intelligent Bio's Stock prices. Below is the latest headlines and news related to Intelligent Bio Solutions Stock. The global stock market is bullish. About 64% of major world exchanges and indexes are currently up. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Intelligent Bio that are available to investors today. This information is accessible both publicly - through Intelligent Bio's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Intelligent-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Intelligent Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Intelligent Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Intelligent Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Intelligent Bio alpha.
Intelligent Largest EPS Surprises
Earnings surprises can significantly impact Intelligent Bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2022-11-09 | 2022-09-30 | -0.1 | -0.08 | 0.02 | 20 | ||
2024-11-07 | 2024-09-30 | -0.53 | -0.7 | -0.17 | 32 | ||
2025-02-13 | 2024-12-31 | -0.27 | -0.5 | -0.23 | 85 | ||
2025-05-13 | 2025-03-31 | -0.1 | -0.44 | -0.34 | 340 | ||
2023-08-23 | 2023-06-30 | -1.49 | -1.91 | -0.42 | 28 | ||
2024-05-08 | 2024-03-31 | -0.87 | -1.43 | -0.56 | 64 |
There is far too much social signal, news, headlines, and media speculation about Intelligent Bio that are available to investors today. This information is accessible both publicly - through Intelligent Bio's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Intelligent-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Intelligent Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Intelligent Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Intelligent Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Intelligent Bio alpha.
Intelligent Bio Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment | 05/19/2025 |
2 | EXCLUSIVE Intelligent Bios Fingerprint Drug Testing Gains Momentum With New Australian Rollout | 06/18/2025 |
3 | EXCLUSIVE Intelligent Bio Targets Global Market With Distribution Pact For Sweat-Based Drug Detection Patch | 07/16/2025 |
4 | Is Intelligent Bio Solutions Inc. a good long term investment - Market-crushing profits - Autocar Professional | 07/21/2025 |
5 | EXCLUSIVE Intelligent Bio Solutions New Data Confirms Ability To Detect Trace Sweat Volumes At Ultra-Micro Level | 07/23/2025 |
6 | Intelligent Bio Solutions Inc. Enters Into Agreements to Raise 3.8 Million in Gross Proceeds | 07/25/2025 |
7 | What are the latest earnings results for Intelligent Bio Solutions Inc. - Top Growth Review With High Returns - jammulinksnews.com | 08/01/2025 |
8 | Intelligent Bio Solutions Strengthens FDA 510 Package with New Cybersecurity and Performance Data Ahead of Planned U.S. Market Launch | 08/06/2025 |
9 | EXCLUSIVE Intelligent Bio Expects Double Digit Topline Growth In Q4 | 08/07/2025 |
Additional Tools for Intelligent Stock Analysis
When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.